检索结果 - Sherry Pierce

Refine Results
  1. 1
    The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemia

    The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemia 由 Jorge E. Cortés, SM O'Brien, Sherry Pierce, MJ Keating, EJ Freireich, HM Kantarjian

    出版 1995
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Results of the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimen in elderly patients with acute lymphocytic leukemia

    Results of the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimen in elderly patients with acute lymphocytic leukemia 由 Susan O’Brien, Deborah A. Thomas, Farhad Ravandi, Stefan Faderl, Sherry Pierce, Hagop M. Kantarjian

    出版 2008
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Effect of Diagnosis (Refractory Anemia With Excess Blasts, Refractory Anemia With Excess Blasts in Transformation, or Acute Myeloid Leukemia [AML]) on Outcome of AML-Type Chemotherapy

    Effect of Diagnosis (Refractory Anemia With Excess Blasts, Refractory Anemia With Excess Blasts in Transformation, or Acute Myeloid Leukemia [AML]) on Outcome of AML-Type Chemother... 由 Elihu H. Estey, Peter F. Thall, Miloslav Beran, Hagop M. Kantarjian, Sherry Pierce, Michael J. Keating

    出版 1997
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Discontinuation of hypomethylating agent therapy in patients with myelodysplastic syndromes or acute myelogenous leukemia in complete remission or partial response: Retrospective analysis of survival after long-term follow-up

    Discontinuation of hypomethylating agent therapy in patients with myelodysplastic syndromes or acute myelogenous leukemia in complete remission or partial response: Retrospective a... 由 Mónica Cabrero, Elias Jabbour, Farhad Ravandi, Zach Bohannan, Sherry Pierce, Hagop M. Kantarjian, Guillermo Garcia‐Manero

    出版 2015
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    A stratification system for evaluating and selecting therapies in patients with relapsed or primary refractory acute myelogenous leukemia [letter]

    A stratification system for evaluating and selecting therapies in patients with relapsed or primary refractory acute myelogenous leukemia [letter] 由 Elihu H. Estey, Steven M. Kornblau, Sherry Pierce, Hagop M. Kantarjian, Miloslav Beran, Michael J. Keating

    出版 1996
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Comparison of thalidomide and lenalidomide as therapy for myelofibrosis

    Comparison of thalidomide and lenalidomide as therapy for myelofibrosis 由 Elias Jabbour, Deborah A. Thomas, Hagop M. Kantarjian, Lingsha Zhou, Sherry Pierce, Jorge E. Cortés, Srđan Verstovšek

    出版 2011
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Prospective feasibility analysis of reduced-intensity conditioning (RIC) regimens for hematopoietic stem cell transplantation (HSCT) in elderly patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS)

    Prospective feasibility analysis of reduced-intensity conditioning (RIC) regimens for hematopoietic stem cell transplantation (HSCT) in elderly patients with acute myeloid leukemia... 由 Elihu H. Estey, Marcos de Lima, Raoul Tibes, Sherry Pierce, Hagop Kantarjian, Richard E. Champlin, Sergio Giralt

    出版 2006
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Incidence of extramedullary disease in patients with acute promyelocytic leukemia: a single-institution experience

    Incidence of extramedullary disease in patients with acute promyelocytic leukemia: a single-institution experience 由 Arturo Vega-Ruiz, Stefan Faderl, Zeev Estrov, Sherry Pierce, Jorge E. Cortés, Hagop M. Kantarjian, Farhad Ravandi

    出版 2009
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Incidence of and risk factors for involvement of the central nervous system in acute myeloid leukemia

    Incidence of and risk factors for involvement of the central nervous system in acute myeloid leukemia 由 Uri Rozovski, Maro Ohanian, Farhad Ravandi, Guillermo Garcia‐Manero, Stefan Faderl, Sherry Pierce, Jorge E. Cortés, Zeev Estrov

    出版 2014
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Randomized Comparison of Cooked and Noncooked Diets in Patients Undergoing Remission Induction Therapy for Acute Myeloid Leukemia

    Randomized Comparison of Cooked and Noncooked Diets in Patients Undergoing Remission Induction Therapy for Acute Myeloid Leukemia 由 Alison Gardner, Gloria Mattiuzzi, Stefan Faderl, Gautam Borthakur, Guillermo Garcia‐Manero, Sherry Pierce, Mark Brandt, Elihu H. Estey

    出版 2008
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    High-grade B-cell lymphomas with TdT expression: a diagnostic and classification dilemma

    High-grade B-cell lymphomas with TdT expression: a diagnostic and classification dilemma 由 Chi Young Ok, L. Jeffrey Medeiros, Beenu Thakral, Guilin Tang, Nitin Jain, Elias Jabbour, Sherry Pierce, Sergej Konoplev

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Activating internal tandem duplication mutations of the fms-like tyrosine kinase-3 (FLT3-ITD) at complete response and relapse in patients with acute myeloid leukemia

    Activating internal tandem duplication mutations of the fms-like tyrosine kinase-3 (FLT3-ITD) at complete response and relapse in patients with acute myeloid leukemia 由 Aziz Nazha, Jorge E. Cortés, S. Faderl, Sherry Pierce, N. Daver, Tapan Kadia, G. Borthakur, Rajyalakshmi Luthra, Hagop Kantarjian, F. Ravandi

    出版 2012
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    Significance of thrombocytopenia in patients with primary and postessential thrombocythemia/polycythemia vera myelofibrosis

    Significance of thrombocytopenia in patients with primary and postessential thrombocythemia/polycythemia vera myelofibrosis 由 Lucia Masárová, Ahmad Alhuraiji, Prithviraj Bose, Naval Daver, Naveen Pemmaraju, Jorge E. Cortés, Sherry Pierce, Hagop M. Kantarjian, Srđan Verstovšek

    出版 2017
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    EUTOS score is not predictive for survival and outcome in patients with early chronic phase chronic myeloid leukemia treated with tyrosine kinase inhibitors: a single institution experience

    EUTOS score is not predictive for survival and outcome in patients with early chronic phase chronic myeloid leukemia treated with tyrosine kinase inhibitors: a single institution e... 由 Elias Jabbour, Jorge E. Cortés, Aziz Nazha, Susan O’Brien, Alfonso Quintás‐Cardama, Sherry Pierce, Guillermo Garcia‐Manero, Hagop M. Kantarjian

    出版 2012
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    Experience with gemtuzumab ozogamycin (“mylotarg”) and all-trans retinoic acid in untreated acute promyelocytic leukemia

    Experience with gemtuzumab ozogamycin (“mylotarg”) and all-trans retinoic acid in untreated acute promyelocytic leukemia 由 Elihu H. Estey, Francis J. Giles, Miloslav Beran, Susan O’Brien, Sherry Pierce, Stefan Faderl, Jorge E. Cortés, Hagop M. Kantarjian

    出版 2002
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    Outcome of adults with acute lymphocytic leukemia after second salvage therapy

    Outcome of adults with acute lymphocytic leukemia after second salvage therapy 由 Susan O’Brien, Deborah Thomas, Farhad Ravandi, Stefan Faderl, Jorge E. Cortés, Gautum Borthakur, Sherry Pierce, Guillermo Garcia‐Manero, Hagop M. Kantarjian

    出版 2008
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    Prediction of Early Death After Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia With Pretreatment Risk Scores: A Novel Paradigm for Treatment Assignment

    Prediction of Early Death After Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia With Pretreatment Risk Scores: A Novel Paradigm for Treatment Assignment 由 Roland B. Walter, Megan Othus, Gautam Borthakur, Farhad Ravandi, Jorge E. Cortés, Sherry Pierce, Frederick R. Appelbaum, Hagop Kantarjian, Elihu H. Estey

    出版 2011
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    The incidence and impact of thrombocytopenia in myelodysplastic syndromes

    The incidence and impact of thrombocytopenia in myelodysplastic syndromes 由 Hagop M. Kantarjian, Francis J. Giles, Alan F. List, Roger M. Lyons, Mikkael A. Sekeres, Sherry Pierce, Robert Deuson, Joseph A. Leveque

    出版 2007
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  19. 19
    Dynamic Model for Predicting Death Within 12 Months in Patients With Primary or Post–Polycythemia Vera/Essential Thrombocythemia Myelofibrosis

    Dynamic Model for Predicting Death Within 12 Months in Patients With Primary or Post–Polycythemia Vera/Essential Thrombocythemia Myelofibrosis 由 Constantine S. Tam, Hagop M. Kantarjian, Jorge E. Cortés, Alice Lynn, Sherry Pierce, Lingsha Zhou, Michael J. Keating, Deborah A. Thomas, Srđan Verstovšek

    出版 2009
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  20. 20
    Lack of Effect of 2-Chlorodeoxyadenosine Therapy in Patients with Chronic Lymphocytic Leukemia Refractory to Fludarabine Therapy

    Lack of Effect of 2-Chlorodeoxyadenosine Therapy in Patients with Chronic Lymphocytic Leukemia Refractory to Fludarabine Therapy 由 Susan O’Brien, Hagop M. Kantarjian, Elihu H. Estey, Charles Koller, Bud Robertson, Miloslav Beran, Michael Andreeff, Sherry Pierce, Michael J. Keating

    出版 1994
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: